dipyridamole has been researched along with Proteinuria in 64 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 9.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 9.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "Dipyridamole was used in 30 cases of nephrotic syndrome, mostly of intractable type." | 9.04 | Dipyridamole therapy in the nephrotic syndrome. ( Koyama, A; Narita, M; Sano, M; Shishido, H; Suzuki, H; Tojo, S; Tsuchida, H; Tsuchiya, T; Yamamoto, S, 1978) |
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 7.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| "The present study was conducted to investigate the antinephritic effects of berberine and coptisine, which are contained in Coptidis rhizoma, on original-type anti-GBM nephritis in rats." | 7.68 | Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis. ( Furuta, K; Hattori, T; Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y, 1992) |
| "The effect of TJ-8014, a lyophilized extract of Syo-Saiko-To without Zingiberis rhizoma, annexing Coptidis rhizoma and Hoelen, on puromycin aminonucleoside (PAN) nephrosis in comparison with the effect of dipyridamole was evaluated." | 7.68 | Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms. ( Hattori, T; Ito, M; Suzuki, Y, 1991) |
| "Nephrosis was induced by single injections of puromycin of aminonucleoside to rats which were divided into two groups; the experimental group receiving dipyridamole in addition to aminonucleoside and the control group receiving aminonucleoside alone." | 7.67 | Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy. ( Honda, N; Kumagai, H; Nagase, M, 1984) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The effect of dipyridamole on proteinuria was studied in 60 children with various renal diseases." | 7.67 | Effect of dipyridamole treatment on proteinuria in pediatric renal disease. ( Ito, S; Kawaguchi, S; Niinomi, Y; Nonoda, T; Ohnishi, M; Ueda, N; Yasaki, T, 1986) |
| "The suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis and protamine-induced proteinuria, was investigated." | 7.66 | Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat. ( Endou, H; Kimura, K; Sakai, F, 1979) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 5.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 5.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 5.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "Dipyridamole was used in 30 cases of nephrotic syndrome, mostly of intractable type." | 5.04 | Dipyridamole therapy in the nephrotic syndrome. ( Koyama, A; Narita, M; Sano, M; Shishido, H; Suzuki, H; Tojo, S; Tsuchida, H; Tsuchiya, T; Yamamoto, S, 1978) |
| "Children with IgA nephropathy showing diffuse (>80%) mesangial proliferation are at high risk for end-stage renal failure (ESRF)." | 3.85 | Long-term results of a randomized controlled trial in childhood IgA nephropathy. ( Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kamei, K; Nakanishi, K; Saito, M; Sako, M; Yoshikawa, N, 2011) |
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 3.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| " This study investigates the effect of acetylsalicylic acid (ASA) combined with dipyridamole on proteinuria and renal function in nephrotic MPGN patients with normal/moderately reduced glomerular filtration rate (GFR)." | 3.71 | Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I. ( Baştürk, T; Harmankaya, O; Karabiber, N; Obek, A; Oztürk, Y, 2001) |
| "The present study was conducted to investigate the antinephritic effects of berberine and coptisine, which are contained in Coptidis rhizoma, on original-type anti-GBM nephritis in rats." | 3.68 | Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis. ( Furuta, K; Hattori, T; Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y, 1992) |
| "The effect of TJ-8014, a lyophilized extract of Syo-Saiko-To without Zingiberis rhizoma, annexing Coptidis rhizoma and Hoelen, on puromycin aminonucleoside (PAN) nephrosis in comparison with the effect of dipyridamole was evaluated." | 3.68 | Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms. ( Hattori, T; Ito, M; Suzuki, Y, 1991) |
| "We investigated the antinephritic effects of TJ-8014, in comparison to dipyridamole, on crescentic-type anti-GBM nephritis in rats." | 3.68 | Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine (3): Effects on crescentic-type anti-GBM nephritis in rats. ( Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y, 1990) |
| "Nephrosis was induced by single injections of puromycin of aminonucleoside to rats which were divided into two groups; the experimental group receiving dipyridamole in addition to aminonucleoside and the control group receiving aminonucleoside alone." | 3.67 | Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy. ( Honda, N; Kumagai, H; Nagase, M, 1984) |
| "In this study, we investigated the antinephritic effects of TJ-8014 and crude drugs in TJ-8014, in comparison to dipyridamole, on original-type anti-GBM nephritis in rats." | 3.67 | Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine, and its mechanisms (1): Effects on original-type anti-GBM nephritis in rats and platelet aggregation. ( Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y, 1989) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The effect of dipyridamole on proteinuria was studied in 60 children with various renal diseases." | 3.67 | Effect of dipyridamole treatment on proteinuria in pediatric renal disease. ( Ito, S; Kawaguchi, S; Niinomi, Y; Nonoda, T; Ohnishi, M; Ueda, N; Yasaki, T, 1986) |
| "The suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis and protamine-induced proteinuria, was investigated." | 3.66 | Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat. ( Endou, H; Kimura, K; Sakai, F, 1979) |
| "Group A comprised 12 patients with IgA nephropathy, who had 24-h proteinuria of 0." | 2.71 | Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy. ( Ikeda, M; Kuwajima, H; Okada, M; Sugimoto, K; Takemura, T; Yagi, K; Yanagida, H, 2003) |
| "Treatment with prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease may prevent immunologic renal injury in children with severe IgA nephropathy." | 2.69 | A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. ( Awazu, M; Hattori, S; Honda, M; Iitaka, K; Ito, H; Ito, K; Koitabashi, Y; Matsuyama, S; Nakagawa, K; Nakamura, H; Ninomiya, M; Sakai, T; Seino, Y; Takeda, N; Takekoshi, Y; Yamaoka, K; Yoshikawa, N, 1999) |
| "We enrolled 35 patients with MPGN type 1 who had a normal creatinine clearance at the time of their first renal biopsy and divided them into 2 groups based on clinical status at the time of their most recent examination: 12 patients with normal urine test results and 12 patients with minor urinary abnormalities at the latest observation (group 1) and 7 patients with persistent nephropathy and 4 patients with renal insufficiency (group 2)." | 1.33 | Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. ( Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M, 2005) |
| "Patients with type II MPGN are usually difficult to treat and often progress to endstage renal failure." | 1.32 | Long-term follow-up of type II membranoproliferative glomerulonephritis in two children. ( Iitaka, K; Iwasaki, N; Koshino, H; Moriya, S; Motoyama, O; Nakamura, S; Sakai, T, 2003) |
| "Three years after the initiation of treatment, proteinuria and hematuria had significantly decreased in both groups, and the renal function in Group B was significantly improved." | 1.29 | Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study. ( Horigome, I; Hotta, O; Kurosawa, K; Sudo, K; Suzuki, K; Taguma, Y, 1993) |
| "Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h protein excretion; the latter amounted to 54% with dipyridamole alone and 56% with dipyridamole plus aspirin (NS)." | 1.28 | Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis. ( Cámara, S; De La Cruz, JP; Frutos, MA; Sánchez De La Cuesta, F, 1992) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 1.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| "Dipyridamole was also given at this time." | 1.27 | Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. ( Zimmerman, SW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (48.44) | 18.7374 |
| 1990's | 19 (29.69) | 18.2507 |
| 2000's | 11 (17.19) | 29.6817 |
| 2010's | 3 (4.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shima, Y | 1 |
| Nakanishi, K | 3 |
| Kaku, Y | 1 |
| Ishikura, K | 3 |
| Hataya, H | 3 |
| Matsuyama, T | 1 |
| Honda, M | 4 |
| Sako, M | 2 |
| Nozu, K | 1 |
| Tanaka, R | 1 |
| Iijima, K | 3 |
| Yoshikawa, N | 4 |
| Kamei, K | 1 |
| Ito, S | 2 |
| Saito, M | 1 |
| Lin, Q | 1 |
| Min, Y | 1 |
| Li, Y | 1 |
| Zhu, Y | 1 |
| Song, X | 1 |
| Xu, Q | 1 |
| Wang, L | 1 |
| Cheng, J | 1 |
| Feng, Q | 1 |
| Li, X | 1 |
| Yamada, M | 1 |
| Sasaki, R | 1 |
| Sato, N | 1 |
| Suzuki, M | 1 |
| Tamura, M | 1 |
| Matsushita, T | 1 |
| Kurumatani, H | 1 |
| Harmankaya, O | 1 |
| Baştürk, T | 1 |
| Oztürk, Y | 1 |
| Karabiber, N | 1 |
| Obek, A | 1 |
| Tanaka, H | 1 |
| Suzuki, K | 2 |
| Nakahata, T | 1 |
| Ito, E | 1 |
| Waga, S | 1 |
| Kano, K | 1 |
| Nishikura, K | 1 |
| Yamada, Y | 1 |
| Arisaka, O | 1 |
| Iitaka, K | 2 |
| Nakamura, S | 1 |
| Moriya, S | 1 |
| Koshino, H | 1 |
| Iwasaki, N | 1 |
| Motoyama, O | 1 |
| Sakai, T | 2 |
| Yagi, K | 1 |
| Okada, M | 1 |
| Yanagida, H | 1 |
| Kuwajima, H | 1 |
| Ikeda, M | 1 |
| Sugimoto, K | 1 |
| Takemura, T | 1 |
| Futrakul, N | 1 |
| Boonyen, M | 1 |
| Patumraj, S | 1 |
| Siriviriyakul, P | 1 |
| Tosukhowong, P | 1 |
| Futrakul, P | 1 |
| Kawasaki, Y | 1 |
| Hosoya, M | 1 |
| Takahashi, A | 1 |
| Isome, M | 1 |
| Tanji, M | 1 |
| Suzuki, H | 2 |
| Locatelli, F | 1 |
| Vecchio, LD | 1 |
| Pozzi, C | 1 |
| Taji, Y | 1 |
| Kuwahara, T | 1 |
| Shikata, S | 1 |
| Morimoto, T | 1 |
| Okada, S | 2 |
| Kurata, N | 1 |
| Ota, Z | 2 |
| Ofuji, T | 1 |
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Nagase, M | 1 |
| Kumagai, H | 1 |
| Honda, N | 1 |
| Aul, C | 1 |
| Scharf, RE | 1 |
| Königshausen, T | 1 |
| Küppers, H | 1 |
| Grabensee, B | 1 |
| Makino, H | 1 |
| Ishikawa, H | 1 |
| Honjo, A | 1 |
| Hayashi, M | 1 |
| Hamaguchi, T | 1 |
| Morita, T | 1 |
| Shindo, T | 1 |
| Tetsutani, T | 1 |
| Yamamoto, T | 1 |
| Okubo, H | 1 |
| Oka, G | 1 |
| Cahen, R | 1 |
| Trolliet, P | 1 |
| Dijoud, F | 1 |
| Megri, K | 1 |
| François, B | 1 |
| Oner, A | 1 |
| Tinaztepe, K | 1 |
| Erdogan, O | 1 |
| Zäuner, I | 1 |
| Böhler, J | 1 |
| Braun, N | 1 |
| Grupp, C | 1 |
| Heering, P | 1 |
| Schollmeyer, P | 1 |
| Vallon, V | 1 |
| Osswald, H | 1 |
| Hotta, O | 1 |
| Taguma, Y | 1 |
| Kurosawa, K | 1 |
| Sudo, K | 1 |
| Horigome, I | 1 |
| Tanaka, S | 1 |
| Shirato, I | 1 |
| Inkyo-Hayasaka, K | 1 |
| Tanaka, A | 1 |
| Kubota, M | 1 |
| Nakayama, S | 1 |
| Tomino, Y | 3 |
| Sanaka, T | 1 |
| Nakano, Y | 1 |
| Nishimura, H | 1 |
| Shinobe, M | 1 |
| Higuchi, C | 1 |
| Omata, M | 1 |
| Nihei, H | 1 |
| Sugino, N | 1 |
| Fu, LW | 1 |
| Yang, LY | 1 |
| Chen, WP | 1 |
| Tsai, SJ | 1 |
| Lin, CY | 1 |
| Ito, H | 1 |
| Takekoshi, Y | 1 |
| Awazu, M | 1 |
| Ito, K | 1 |
| Koitabashi, Y | 1 |
| Yamaoka, K | 1 |
| Nakagawa, K | 1 |
| Nakamura, H | 1 |
| Matsuyama, S | 1 |
| Seino, Y | 1 |
| Takeda, N | 1 |
| Hattori, S | 1 |
| Ninomiya, M | 1 |
| Lindeman, RD | 1 |
| Tojo, S | 3 |
| Narita, M | 2 |
| Koyama, A | 2 |
| Sano, M | 1 |
| Tsuchiya, T | 1 |
| Tsuchida, H | 1 |
| Yamamoto, S | 1 |
| Shishido, H | 1 |
| Ueda, Y | 1 |
| Hatano, M | 1 |
| Furukawa, T | 1 |
| Yoshinaga, K | 1 |
| Kinoshita, Y | 1 |
| Takeuchi, J | 1 |
| Kato, E | 1 |
| Ohno, J | 2 |
| Kobayashi, K | 1 |
| Abe, H | 1 |
| Omae, S | 1 |
| Kimura, K | 1 |
| Endou, H | 1 |
| Sakai, F | 1 |
| Kampf, D | 1 |
| Höfer, W | 1 |
| Misgeld, V | 1 |
| Howie, PW | 1 |
| Prentice, CR | 1 |
| Forbes, CD | 1 |
| De La Cruz, JP | 1 |
| Cámara, S | 1 |
| Frutos, MA | 1 |
| Sánchez De La Cuesta, F | 1 |
| Hattori, T | 5 |
| Furuta, K | 1 |
| Nagao, T | 1 |
| Nagamatsu, T | 3 |
| Ito, M | 6 |
| Suzuki, Y | 5 |
| Okada, N | 1 |
| Aizawa, T | 1 |
| Yokokawa, N | 1 |
| Kobayashi, M | 1 |
| Moriya, T | 1 |
| Shigematsu, S | 1 |
| Shirota, T | 1 |
| Komatsu, M | 1 |
| Shinoda, T | 1 |
| Yamada, T | 1 |
| Gordge, MP | 1 |
| Rylance, PB | 1 |
| Neild, GH | 1 |
| Ushijima, H | 1 |
| Aiko, A | 1 |
| Nakamura, T | 1 |
| Yoshimura, T | 1 |
| Okamura, H | 1 |
| Uzan, S | 1 |
| Beaufils, M | 1 |
| Breart, G | 1 |
| Bazin, B | 1 |
| Capitant, C | 1 |
| Paris, J | 1 |
| Nĕmecek, K | 1 |
| Petrů, I | 1 |
| Knotková, V | 1 |
| Jáchymová, M | 1 |
| Hopper, AH | 1 |
| Tindall, H | 1 |
| Davies, JA | 1 |
| Hachicha, J | 1 |
| Ammous, A | 1 |
| Damak, J | 1 |
| Hammami, M | 1 |
| Ghorbel, A | 1 |
| Rekik, S | 1 |
| Jarraya, A | 1 |
| Kobayashi, Y | 1 |
| Hiki, Y | 1 |
| Fujii, K | 1 |
| Kurokawa, A | 1 |
| Tateno, S | 1 |
| Izumino, K | 2 |
| Iida, H | 2 |
| Asaka, M | 2 |
| Mizumura, Y | 1 |
| Sasayama, S | 2 |
| Yagame, M | 1 |
| Miura, M | 1 |
| Suga, T | 1 |
| Endoh, M | 1 |
| Nomoto, Y | 1 |
| Sakai, H | 2 |
| de Jong, PE | 1 |
| van der Meer, J | 1 |
| van der Hem, GK | 1 |
| de Zeeuw, D | 1 |
| Hanzawa, S | 1 |
| Kitajima, T | 1 |
| Sakai, O | 1 |
| Donadio, JV | 1 |
| Ilstrup, DM | 1 |
| Holley, KE | 1 |
| Romero, JC | 1 |
| Ueda, N | 1 |
| Kawaguchi, S | 1 |
| Niinomi, Y | 1 |
| Nonoda, T | 1 |
| Ohnishi, M | 1 |
| Yasaki, T | 1 |
| Zimmerman, SW | 1 |
| Inage, H | 1 |
| Banerjee, S | 1 |
| Sharma, VK | 1 |
| Pareek, SK | 1 |
| Ratnu, KS | 1 |
| Kan, K | 1 |
| Wada, T | 1 |
| Kitamoto, K | 1 |
| Konishi, K | 1 |
| Ozawa, Y | 1 |
| Arieff, AI | 1 |
| Pinggera, WF | 1 |
| George, CR | 1 |
| Slichter, SJ | 1 |
| Quadracci, LJ | 1 |
| Striker, GE | 1 |
| Harker, LA | 1 |
| Ponticelli, C | 1 |
| Imbasciati, E | 1 |
| Tarantino, A | 1 |
| Graziani, G | 1 |
| Redaelli, B | 1 |
| Kincaid-Smith, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy[NCT00367562] | Phase 4 | 20 participants | Interventional | 1996-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for dipyridamole and Proteinuria
| Article | Year |
|---|---|
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipyridamole; Disease Progression; Drug Therapy, Combinati | 2006 |
Meta-analysis of antiplatelet therapy for IgA nephropathy.
Topics: Dilazep; Dipyridamole; Glomerulonephritis, IGA; Humans; Kidney Function Tests; Platelet Aggregation | 2006 |
16 trials available for dipyridamole and Proteinuria
| Article | Year |
|---|---|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Topics: Adolescent; Biopsy; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Gl | 2018 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combinati | 2003 |
Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
Topics: Adolescent; Child; Dipyridamole; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fl | 2003 |
Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Topics: Adolescent; Adult; Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; | 2003 |
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA | 2008 |
The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis.
Topics: Adolescent; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephr | 1995 |
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Blood Pressure; Dietary Proteins; | 1994 |
IgG subclass/IgM ratio and response to therapy in focal segmental glomerulonecrosis.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclophosphamide; Dipy | 1998 |
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Topics: Adolescent; Azathioprine; Blood Urea Nitrogen; Child; Dipyridamole; Drug Therapy, Combination; Glome | 1999 |
Dipyridamole therapy in the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Therapy, Comb | 1978 |
[Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
Topics: Adolescent; Adult; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Humans; Male | 1979 |
[The effects of dipyridamole on proteinuria in preeclampsia].
Topics: Adult; Dipyridamole; Female; Humans; Pre-Eclampsia; Pregnancy; Proteinuria | 1992 |
Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.
Topics: Adult; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug | 1991 |
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Blind Method | 1989 |
Clinical effect of danazol in patients with IgA nephropathy.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Complement C3; Complement C4; Danazol; Dipyri | 1987 |
46 other studies available for dipyridamole and Proteinuria
| Article | Year |
|---|---|
Henoch-Schönlein purpura with hypocomplementemia.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antistreptolysin; Autoantibodies; Biopsy; Child; Ch | 2012 |
Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Blood Pressure; Blood U | 2002 |
Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Creatinine; Dipyridamole; Drug | 2001 |
Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Topics: Basement Membrane; Biopsy; Child; Dipyridamole; Female; Follow-Up Studies; Glomerular Mesangium; Glo | 2003 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug | 2003 |
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosp | 2005 |
Effect of dipyridamole on proteinuria of nephrotic syndrome.
Topics: Adult; Dipyridamole; Humans; Male; Nephrotic Syndrome; Proteinuria | 1981 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
Topics: Animals; Basement Membrane; Cell Membrane Permeability; Dipyridamole; Glomerular Filtration Rate; Hy | 1984 |
[Differential therapy of thrombotic-thrombopenic purpura. Administration of fresh plasma versus plasma separation].
Topics: Acute Kidney Injury; Adult; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Erythrocytes; | 1984 |
Effect of dipyridamole on proteinuria of diabetic nephropathy.
Topics: Diabetic Nephropathies; Dipyridamole; Humans; Male; Middle Aged; Proteinuria | 1983 |
Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Dipyridamole; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nephro | 1982 |
Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
Topics: Adult; Creatinine; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis, Membranoprolife | 1995 |
Dipyridamole prevents diabetes-induced alterations of kidney function in rats.
Topics: Adenosine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipyridamole; Glomerular Filtrat | 1994 |
Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Topics: Adolescent; Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Stud | 1993 |
Case report: late relapse in a case of mesangioproliferative glomerulonephritis.
Topics: Adult; Biopsy; Dipyridamole; Female; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative | 1996 |
Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.
Topics: Animals; Antioxidants; Dipyridamole; Free Radical Scavengers; Immune Complex Diseases; Kidney; Kidne | 1997 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid | 1977 |
Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
Topics: Albuminuria; Animals; Dipyridamole; Male; Nephrosis; Protamines; Proteinuria; Puromycin; Puromycin A | 1979 |
[Anticoagulation and immunosuppression in rapidly progressive glomerulonephritis of poststreptococcal type (author's transl)].
Topics: Adolescent; Anticoagulants; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Heparin; Humans; Imm | 1978 |
Failure of heparin therapy to affect the clinical course of severe pre-eclampsia.
Topics: Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dipyridamole; Disseminated Intravascular | 1975 |
Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hum | 1992 |
Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Berberine; Cholesterol; Creatinine; Dipyridamole; Drug Evalua | 1992 |
Abnormal molecular weight profile of urinary protein in rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipyridamole; Electrophoresis, | 1992 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Dr | 1992 |
Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine (4): Effects on accelerated passive Heymann nephritis in rats.
Topics: Adrenal Glands; Animals; Antibody Formation; Basement Membrane; Cholesterol; Complement C3; Corticos | 1990 |
Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
Topics: Animals; Catalase; Cholesterol; Dipyridamole; Drugs, Chinese Herbal; Glutathione Peroxidase; Kidney | 1991 |
Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine (3): Effects on crescentic-type anti-GBM nephritis in rats.
Topics: Animals; Antibodies; Autoantibodies; Blood Urea Nitrogen; Cholesterol; Dipyridamole; Drugs, Chinese | 1990 |
[The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Female; Glomerular Filtration Rate; Glomerulonephriti | 1990 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pr | 1989 |
Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine, and its mechanisms (1): Effects on original-type anti-GBM nephritis in rats and platelet aggregation.
Topics: Animals; Antibodies; Basement Membrane; Blood Urea Nitrogen; Body Weight; Dipyridamole; Drugs, Chine | 1989 |
Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Dipyridamol | 1989 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
Topics: Animals; Antibodies; Antigen-Antibody Complex; Cattle; Creatinine; Dipyridamole; Fluorescent Antibod | 1986 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
Topics: Animals; Dipyridamole; Immune Complex Diseases; Nephritis; Platelet Aggregation; Proteinuria; Rats; | 1987 |
Clinical effect of dipyridamole in patients with IgA nephropathy.
Topics: Adrenochrome; Dipyridamole; Glomerulonephritis; Glomerulonephritis, IGA; Hematuria; Humans; Proteinu | 1986 |
Is the antiproteinuric effect of dipyridamole hemodynamically mediated?
Topics: Dipyridamole; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Transplantation; M | 1988 |
Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Creatinine; Diabetic Nephropathies; Dipyridamole; Dr | 1988 |
Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Dipyridamole; Female; Glomerulonephritis; Glom | 1986 |
Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis.
Topics: Adult; Creatinine; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Ki | 1985 |
Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.
Topics: Adolescent; Adult; Azepines; Blood Platelets; Dilazep; Dipyridamole; Female; Humans; Male; Middle Ag | 1985 |
Antiproteinuric effect of indomethacin and dipyridamole in various glomerulopathies of adults.
Topics: Adolescent; Dipyridamole; Glomerulonephritis; Humans; Indomethacin; Proteinuria | 1985 |
Dipyridamole for proteinuria suppression. Use in a patient with proliferative glomerulonephritis.
Topics: Adolescent; Biopsy; Dipyridamole; Glomerulonephritis; Hematuria; Humans; Kidney Glomerulus; Male; Pr | 1974 |
Rapidly progressive glomerulonephritis treated with anticoagulants.
Topics: Adult; Aged; Anticoagulants; Azathioprine; Blood Urea Nitrogen; Creatinine; Dipyridamole; Diuresis; | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin | 1974 |
Post-partum renal failure with microangiopathic haemolytic anaemia. Long-term survival after anticoagulant therapy.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Anticoagulants; Blood Platelet Disorders; Cesarean Se | 1972 |
The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
Topics: Anticoagulants; Biopsy; Cyclophosphamide; Dipyridamole; Drug Combinations; Erythrocyte Count; Female | 1972 |